Literature DB >> 17302184

Insulin-like growth factor-related signaling and cancer development.

Michael Pollak1.   

Abstract

In this review, selected examples of recent research developments concerning insulin-like growth factors (IGFs) and insulin in the context of cancer risk assessment and prevention will be discussed. We reviewed background information related to IGF physiology at the cellular and whole-organism levels, together with prior work concerning IGF-I levels and risk of a variety of cancers, including breast, prostate, colon, and lung in 2004 (Pollak et al. 2004). A comprehensive update to that general review (Pollak et al. 2004) is scheduled for Nature Reviews Cancer in early 2007.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17302184     DOI： 10.1007/978-3-540-37696-5_4

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  22 in total

Review 1.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 2.  Metformin and cancer.

Authors:  Natalia G Vallianou; Angelos Evangelopoulos; Christos Kazazis
Journal:  Rev Diabet Stud       Date:  2014-02-10

3.  Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma.

Authors:  Chong-Yi Jiang; Wei Wang; Yu-Lei Yin; Zu-Rong Yuan; Liu-Bo Wang
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

Review 4.  Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Authors:  Vladimir N Anisimov
Journal:  Ann Transl Med       Date:  2014-06

5.  Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth.

Authors:  Patrick B White; Eben M True; Kathryn M Ziegler; Sue S Wang; Deborah A Swartz-Basile; Henry A Pitt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2010-09-22       Impact factor: 3.452

Review 6.  Targeting the insulin growth factor receptor 1.

Authors:  Fernanda I Arnaldez; Lee J Helman
Journal:  Hematol Oncol Clin North Am       Date:  2012-02-28       Impact factor: 3.722

7.  The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.

Authors:  Peng-Ju Zhang; Xiao-Yan Hu; Chun-Yan Liu; Zhao-Bo Chen; Na-Na Ni; Yang Yu; Li-Na Yang; Zhao-Qin Huang; Qing-Wei Liu; An-Li Jiang
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

Review 8.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

9.  Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Chunxia Du; Annacarolina da Silva; Vicente Morales-Oyarvide; Brian M Wolpin; Jonathan A Nowak; Andressa Dias Costa; Margaret M Kozak; Richard F Dunne; Douglas A Rubinson; Kimberly Perez; Yohei Masugi; Tsuyoshi Hamada; Lauren K Brais; Chen Yuan; Ana Babic; Matthew D Ducar; Aaron R Thorner; Andrew Aguirre; Matthew H Kulke; Kimmie Ng; Thomas E Clancy; Jennifer J Findeis-Hosey; Daniel T Chang; Jason L Hornick; Charles S Fuchs; Shuji Ogino; Albert C Koong; Aram F Hezel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

10.  Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.

Authors:  Cecilia Garofalo; Caterina Mancarella; Andrea Grilli; Maria Cristina Manara; Annalisa Astolfi; Maria Teresa Marino; Alexia Conte; Sara Sigismund; Alessandra Carè; Antonino Belfiore; Piero Picci; Katia Scotlandi
Journal:  Mol Endocrinol       Date:  2012-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.